Related Articles
Phase â…¡ trial of granulocyte-macrophage colony-stimulating factor plus thalidomide in older patients with castration-resistant prostate cancer
Clinical predictor of survival following docetaxel‑based chemotherapy
Survival after cytotoxic chemotherapy in patients with advanced hormone-resistant prostate cancer: A phase II study
Low-dose docetaxel, estramustine and prednisolone combination chemotherapy for castration-resistant prostate cancer
Response to 223Ra-dichloride in castration-resistant prostate cancer with bone metastasis: A case report